problems with cryptocurrency- Top searches

Starbucks China responded to the new Chief Growth Officer: promoting the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. (Sina Technology)Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.On the 11th, the director of the Crime Investigation Department of Senior Public Officials in South Korea said that if the situation is urgent, he would try to arrest the president urgently.

Trader: The Indian central bank is suspected of selling dollars to limit the depreciation of Indian Rupee.South Korea's former defense minister tried to commit suicide in prison. The Korean Ministry of Justice disclosed details. According to Yonhap News Agency's report on the 11th, South Korea's former defense minister Jin Longxian attempted suicide in prison on the evening of 10th. In response, Shen Ronghai, head of the Department of Corrections of the Korean Ministry of Justice, said that at present, Jin Longxian "has no abnormal physical condition." According to the report, Shen Ronghai said on the 11th that at around 11: 52 last night (10th), before the arrest warrant was issued, the staff found him trying to connect clothes into a rope in the bathroom in an attempt to commit suicide. Shen Ronghai added that the staff immediately took action and opened the door, and then Jin Longxian gave up suicide. At present, Jin Longxian has been placed in the protection room, and according to the report, his physical condition is not abnormal for the time being. (Yonhap News Agency)Citigroup: cut the iron ore price forecast from $110 per ton to $100 per ton.

 Institution: In the first half of 2024, the scale of China's edge cloud market increased by 21% year-on-year. Recently, the latest report "China Edge Cloud Market Tracking Research, 2024H1" released by International Data Corporation (IDC) shows that in the first half of 2024, the scale of China's edge cloud market totaled 5.48 billion yuan, with a year-on-year growth rate of 21.0%. Among them, the market scale of edge public cloud services, edge exclusive cloud services and edge cloud solutions reached RMB 3.00 billion, RMB 970 million and RMB 1.50 billion respectively. Internet audio and video distribution and real-time interaction based on edge resources, edge game clothes, cloud terminals and cloud games, cloud network services, and lightweight IT architecture migration of local industry customers are the core driving forces for market growth in this period.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.